BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15735049)

  • 1. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
    Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
    Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.
    Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF
    Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers.
    Port M; Boltze C; Wang Y; Röper B; Meineke V; Abend M
    Radiat Res; 2007 Dec; 168(6):639-49. PubMed ID: 18088181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression and the biological phenotype of papillary thyroid carcinomas.
    Delys L; Detours V; Franc B; Thomas G; Bogdanova T; Tronko M; Libert F; Dumont JE; Maenhaut C
    Oncogene; 2007 Dec; 26(57):7894-903. PubMed ID: 17621275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles in thyroid carcinomas.
    Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
    Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles for radiation-induced thyroid cancer.
    Maenhaut C; Detours V; Dom G; Handkiewicz-Junak D; Oczko-Wojciechowska M; Jarzab B
    Clin Oncol (R Coll Radiol); 2011 May; 23(4):282-8. PubMed ID: 21411301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
    Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
    Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene expression analysis by DNA microarray in papillary thyroid cancer].
    Gubała E; Wiench M; Oczko-Wojciechowska M; Lange D; Włoch J; Czarniecka A; Chmielik E; Nikiel B; Wygoda Z; Kukulska A; Handkiewicz-Junak D; Szpak-Ulczok S; Krawczyk A; Roskosz J; Jarzab B
    Endokrynol Pol; 2005; 56(5):752-7. PubMed ID: 16817140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered chemokine receptor expression in papillary thyroid cancer.
    González HE; Leiva A; Tobar H; Böhmwald K; Tapia G; Torres J; Mosso LM; Bueno SM; Gonzalez P; Kalergis AM; Riedel CA
    Thyroid; 2009 Sep; 19(9):957-65. PubMed ID: 19731977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.